Eiz-Vesper, Britta, Ravens, Sarina, Maecker-Kolhoff, Britta · Current opinion in immunology · 2023 · DOI
This review article examines how the immune system responds to Epstein-Barr Virus (EBV), a common virus that can cause chronic fatigue syndrome and other serious diseases. The authors focus on understanding why some people's immune systems fail to control EBV, particularly in transplant patients, and discuss potential treatments that could help strengthen the immune response against this virus.
Understanding EBV immune responses is directly relevant to ME/CFS, as EBV is one of the pathogens most strongly associated with ME/CFS onset and persistence. This review synthesizes knowledge about why some people cannot adequately control EBV infection, which may inform understanding of the immunological mechanisms underlying ME/CFS. The discussion of therapeutic approaches to augment anti-EBV immunity could inform future treatment strategies for ME/CFS patients.
This review does not prove that EBV causes ME/CFS, only that it is associated with it and appears in disease lists. It does not provide primary experimental data or controlled studies demonstrating efficacy of any particular therapeutic approach. The focus on transplant populations limits direct applicability to ME/CFS patients, who are typically immunocompetent rather than immunosuppressed.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →